>2023 another year to forget, but management optimistic about the future - Last year (2023) was again disappointing for Cherry, with it missing initial guidance by a mile on both revenue (€ 126.5m vs c. € 140m guidance, down 4.5% y-o-y) and adjusted EBITDA margin (1.6% vs guidance of c. 10%). The poor 2023 results were due to a mix of internal and external factors. First, management was running a business with a lack of focus (very diversified product portfolio), no d...
>Le CA T1 reflète une croissance plus favorable que prévu à +11% mais les marges restent du même ordre de grandeur que l’an passé sur le trimestre - Le groupe publie en même temps les résultats annuels 2023 complets (les principales données avaient déjà été communiquées le 29 février) et ceux afférents au T1 2024. Le CA 2023 est confirmé à 1969 M€ soit une croissance de 12% et c.8% en organique (CA T4 à 7% soit quasi flat en org avec une Allemagne à -3.5%), l’EBT ...
With Q1 sales and EBITDA both up 11% YoY, FIE has reassured the market despite a demanding comparison base and challenging macro environment, particularly in Germany. Similarly, FY24 sales outlook highlights robust top-line trends through the year, whilst FIE's prudent EBITDA target leaves some ups
Latest Kantar French market share data highlight a continued and surprising outperformance by Leclerc (+80bp) despite very tough comps vs. other independents and Lidl (slightly up) and vs. integrated groups (down 100bp). The wide gap between Leclerc and Intermarché, Systeme U and Lidl in a fast-dec
Two Directors at Cleveland-Cliffs Inc bought 85,000 shares at between 16.761USD and 16.995USD. The significance rating of the trade was 84/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors ov...
>A strong operating performance from the three business lines - Altarea reported a performance for Q1 2024 (revenues € 578.9m, +4% y-o-y) which reflects above all an outperformance from retail but also the end of the clearing of the housing supply from the previous cycle while business property is making progress.Retail (revenues € 67.3m, +11.8% y-o-y): all indicators are showing a very positive trend and above peers with: 1/ retailer sales at +7% y-o-y for foot...
>The underlying strategic rationale is still there… - In a surprise move, BBVA announced its concrete/formal interest in Banco Sabadell the day after reporting its Q1 2024 results and probably following a leak in the media. It is still too early, in the absence of details around the terms, to properly evaluate the relevance of the move (we clearly maintain our positive stance on the stock and our target price at this stage), although we can already provide an initial ...
>Croissance à cc en ligne avec les attentes. Bookings solides - Capgemini a annoncé mardi avant Bourse un CA T1 2024 satisfaisant, avec une variation cc de -3.3%, +20 pb au-dessus des attentes. L’Amérique du Nord continue à être pénalisée par un mix moins favorable (-7.1% cc) alors que l’Europe continue à faire preuve d'une plus grande résilience, enregistrant un léger ralentissement de la croissance, comme prévu (-1.8% cc). Les secteurs TMT et services financiers so...
Shell announces commencement of a share buyback programme Shell plc Shell announces commencement of a share buyback programme May 2, 2024 Shell plc (the ‘Company’) today announces the commencement of a $3.5 billion share buyback programme covering an aggregate contract term of approximately three months (the ‘programme’). The purpose of the programme is to reduce the issued share capital of the Company. All shares repurchased as part of the programme will be cancelled. It is intended that, subject to market conditions, the programme will be completed prior to the Company’s Q2 20...
EQS-News: Defence Therapeutics Inc. / Key word(s): Miscellaneous PANCREACTIC CANCER: SUCCESFUL TRIAL AGAINST PANCREATIC CANCER WITH DEFENCE’S ARM-002 ANTI-CANCER VACCINE 02.05.2024 / 08:00 CET/CEST The issuer is solely responsible for the content of this announcement. _________________________________________________________________ CSE: DTC FSE: DTC USOTC: DTCFF PRESS RELEASE PANCREACTIC CANCER: SUCCESFUL TRIAL AGAINST PANCREATIC CANCER WITH DEFENCE’S ARM-002 ANTI-CANCER VACCINE Vancouver, BC, Canada, May 1st, 2024 - Defence Therapeutics Inc. (“Defenc...
Gulf Keystone Petroleum Ltd (GKP) Block Listing Six Monthly Return 02-May-2024 / 07:00 GMT/BST 2 May 2024 Gulf Keystone Petroleum Ltd. (LSE: GKP) (“Gulf Keystone”, “GKP” or “the Company”) Block Listing Six Monthly Return (Note: Italicised terms have the same meaning as given in the Listing Rules.) Name of applicant: Gulf Keystone Petroleum Limited Name of scheme: Deferred Bonus Plan/Long Term Incentive Plan Period of return: From: 3 November 2023 To: 2 May 2024 ...
Cairn Homes Plc (CRN) Cairn Homes Plc: Transaction in Own Shares 02-May-2024 / 07:00 GMT/BST 02 May 2024 Cairn Homes plc (the “Company”) Transaction in own shares The Company announces that on 1st of May 2024 it purchased a total of 43,299 of its ordinary shares of EUR 0.001 each (the "ordinary shares") on Euronext Dublin and the London Stock Exchange through the Company's broker Goodbody Stockbrokers UC (“Goodbody”), as detailed below. The repurchased shares will be cancelled. Euronext Dublin London Stock Exchange Number of ord...
Ørsted A/S (Orsted) Interim report for the first quarter of 2024 – Operating profit in line with expectations, with offshore site earnings increasing 18 %. Business plan progressing with Sunrise Wind award and completion of two offshore wind farms 02-May-2024 / 07:59 CET/CEST 2.5.2024 07:59:37 CEST | Ørsted A/S | Interim report (Q1 and Q3) Today, Ørsted’s Board of Directors approved the interim report for the first quarter of 2024. Mads Nipper, Group President and CEO of Ørsted, says in a comment to the interim report for the first quarter of 2024:“We are working diligently on ex...
Shell plc First Quarter 2024 Interim Dividend London, May 2, 2024 − The Board of Shell plc (the “Company”) today announced an interim dividend in respect of the first quarter of 2024 of US$ 0.344 per ordinary share. Details relating to the first quarter 2024 interim dividend Per ordinary share Q1 2024 Shell Shares (US$) 0.344 Shareholders will be able to elect to receive their dividends in US dollars, euros or pounds sterling. Absent any valid election to the contrary, persons holding their ordinary shares through Euroclear Nederland will receive their ...
Shell plc publishes first quarter 2024 press release London, May 2, 2024 "Shell delivered another quarter of strong operational and financial performance, demonstrating our continued focus on delivering more value with less emissions. We continue to deliver on our Capital Markets Day targets, giving us the confidence to commence another $3.5 billion buyback programme for the next three months." Shell plc Chief Executive Officer, Wael Sawan DELIVERING STRONG Q1 RESULTS Q1 2024 Ad...
As we may be getting closer to rate cuts by the ECB, we have upgraded CTP to BUY (from Hold), hiking our 12M price target (PT) to EUR 18.9/share. The risks related to CTP’s fairly high LTV (in the mid-40s) and the possibility of further yield expansion, which we flagged in our initiation (February 2023) are still relevant. However, values have been more resilient than we expected, as the demand for logistics space remained robust even when economic growth slowed down. This means that higher rent...
>Solid Q1 results, in line with our estimates… - Aena´s Q1 2024 results were in line with our estimates: revenue and EBITDA were +1.2% and +1.4%, ahead of our estimates, respectively, with the Spanish network +1.8% and +3.1% above (or € 18m and € 16m). The positive note of the results, in our view, came from the good Opex management at the Spanish network as, despite the continued upward trend already anticipated by the company, Opex grew below the traffic growth in ...
>Opinion Surperformance confortée – OC porté à 6.4 € (vs 5.9 €) - Les chiffres T1 2024 de CABK viennent confirmer la tendance favorable à la fois sur le plan opérationnel validant voire améliorant les guidances (RoTE dorénavant attendu >16%) et bilanciel (CET1 FL >12%) en 2024. Cette robustesse, couplée à la diversification adéquate du business model, conforte le titre parmi nos top picks au sein du secteur dans le contexte actuel incertain/challenging (macro, taux…)....
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.